Hepatitis B virus (HBV) is a virus whose replication cycle cannot be completely reproduced using cultured cell lines. Here, we report an engineered cell line capable of supporting the complete HBV life cycle. We generated HepG2 cells over-expressing the HBV entry receptor human NTCP (sodium taurocholate cotransporting polypeptide), and defective in RIG-I (retinoic acid-inducible gene-I)-like receptor signaling, by knocking down the IPS-1 (IFNβ-promoter stimulator-1) adaptor molecule. The resultant NtG20.i7 cells were susceptible to HBV, and its replication was detectable at 14 days postinfection and persisted for at least 35 days with a gradual increase of HBV core expression. The cells produced infectious HBV in the culture supernatant, and the addition of preS1 peptide myr47-WT, which blocks HBV entry, impaired the persistence of the infection. These findings suggest that the persistence of the infection was maintained by continuous release of infectious HBV virions and their re-infection. This system is useful for expanding our basic understanding of the HBV replication cycle and for screening of anti-HBV chemicals.
Introduction
About 400 million individuals worldwide are infected with hepatitis B virus (HBV), causing ~1.2 million deaths annually from cirrhosis, chronic hepatitis B, hepatocellular carcinoma and liver damage (1) (2) (3) (4) (5) . One of the reasons why so few anti-viral drugs are available for HBV treatment is the lack of a stable cell culture system for HBV replication (6) (7) (8) (9) . Primary hepatocytes support HBV replication for a short period. Mice carrying human livers can support HBV replication for a long time; however, they are not suitable for chemical library screening and are expensive (10, 11) . It is expected that the establishment of a cell culture system for HBV will greatly facilitate the development of anti-HBV chemicals acting by distinct mechanisms.
Sodium taurocholate cotransporting polypeptide (NTCP) has been identified as a functional HBV entry receptor (12) . NTCP mediates absorption of the HBV virion through a specific interaction with the N-terminus of the preS1 domain. Furthermore, it was shown that ectopic expression of NTCP in a liver cell line confers susceptibility to HBV infection (13) (14) (15) . It is known that viral nucleic acids are recognized by several sensors, including retinoic acid-inducible gene-I (RIG-I)-like receptors, TLRs and cytoplasmic DNA sensors (16) (17) (18) (19) . Upon activation of these sensors, anti-viral programs are triggered to restrict viral replication (20) (21) (22) . Therefore, it is probable that removal of critical components of innate immunity will facilitate HBV replication. Indeed, it was demonstrated that RIG-I acts as an HBV sensor for stimulating innate signaling to restrict HBV replication (23) (24) (25) .
Here, we report the generation of a HepG2-derived cell line with constitutive expression of NTCP and impaired RIG-Ilike receptor (RLR) signaling. This cell line, termed NtG20.i7, supported HBV replication for up to 35 days with production of infectious HBV in the culture supernatant. Our study suggested that NtG20.i7 reproduced the complete HBV replication cycle and de novo infection in a long-term cultivation. This system will be useful for screening anti-HBV chemical libraries for developing new tools to fight against HBV.
Methods

Cell culture
Except for where otherwise mentioned, cells were maintained in DMEM with 10% fetal bovine serum, 100 U ml −1 penicillin and 100 µg ml −1 streptomycin (common medium) at 37°C in a 5% CO 2 incubator. ES2 cells, which stably express 1.3-fold HBV genome, constitutively produce infectious HBV in the culture supernatant (26) . Hep38.7-Tet cells, established by Naoki Ogura (27) , produce infectious HBV in a tetracyclinesuppressive manner. Hep38.7-Tet cells were maintained in the common medium in the presence of tetracycline (400 ng ml −1 ). NtG20 cells, stably expressing human NTCP, were cultured in common medium with 500 µg ml −1 G418. NtG20.i7 cells, a stable cell line expressing human NTCP with a knockdown of IFNβ-promoter stimulator-1 (IPS-1), were maintained in common medium with 400 µg ml −1 G418 and 100 µg ml −1 Hygromycin B.
Plasmids and transfection
HepG2 cells stably expressing human NTCP-turbo GFP (tGFP) fusion were established by transfecting an expression vector for human NTCP (NM_003049, Human cDNA ORF Clone, Origene Technologies, Inc.) C-terminally fused with tGFP using Lipofectamine 2000 (Life Technologies) and selected using G418 (500 µg ml −1 ). Cells expressing NTCPtGFP were selected by FACS sorting and several clones were obtained. One of the clones, NtG20, was finally chosen due to its high NTCP expression. Using NtG20, we further selected a clone that could stably knockdown IPS-1 by transfecting a shRNA construct, psiRNA-h7SK (InvivoGen) and using Hygromycin B (100 µg ml −1 ). The cells were cloned for stable expression of NTCP-tGFP and knockdown for IPS-1. One of the clones, NtG20.i7, was finally selected.
RNA interference
The synthetic siRNA for negative controls (Invitrogen, Cat. No. 1293-112), IPS-1 (Invitrogen, Cat. No. BS-D20) and STING (Bonac Corporation 5122418) were transfected into ES2 cells with RNAi MAX (Invitrogen) and cultivated with opti-MEM according to the manufacturer's instructions.
RNA extraction and real-time PCR
Total RNA was isolated with TRIzol (Invitrogen) and reverse transcribed using a TaqMan MicroRNA Reverse Transcription Kit to produce cDNA. Real-time PCR (RT-PCR) for NTCP and HBV core (HBc) and HBV surface (HBs) (based on accession number of HBV genome: AB644287) was performed using a Fast SYBR Green Master Mix (Applied Biosystems) according to the manufacturer's protocol. The human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was used as an internal control to normalize differences in each sample. The sequences of primers were:
HBc forward, 5′-TTCACCTCACCATACAGCACTC-3′ HBc reverse, 5′-ATAGGGGCATTTGGTGGTCTG-3′ HBs forward, 5'-AATCCTCACAATACCGCAGA-3' HBs reverse, 5′-AGGCATAGCAGCAGGATGAA-3′ GAPDH forward, 5′-TGCACCACCAACTGCTTAGC-3′ GAPDH reverse, 5′-GGCATGGACTGTGGTCATGAG-3′ NTCP forward, 5′-AGTTCAGCAAGATCAAGGCT-3′ NTCP reverse, 5′-ATGGCCAGACTGAAGACATT-3′
HBV infection
The culture medium of Hep38.7-Tet cells was used for HBV inoculum. Hep38.7-Tet cells were seeded with tetracycline, and after 1 day of cultivation, the cells were washed and cultivated for 6 more days in the absence of tetracycline. The supernatant was harvested and concentrated using a Centricon (Millipore) to 1/20 of the original volume. Cells were seeded in six-well plates at 10 5 cells per well with dHCGM (DMEM supplemented with 10% fetal bovine serum, 1 µg ml −1 of penicillin, 1 µg ml −1 of streptomycin, 20 mM HEPES, 15 µg ml −1 of l-proline, 0.25 µg ml −1 of human recombinant insulin, 50 nM dexamethazone, 5 ng ml −1 of human recombinant epidermal growth factor, 0.1 mM ascorbic acid and 2% DMSO) (28) containing condensed HBV and polyethylene glycol 8000 (4%) for 24 h. The next day, the medium was replaced with fresh dHCGM.
Enzyme-linked immunosorbent assay
Culture supernatants were analyzed using HBs ELISA (Beacle, Inc.) according to the manufacturer's protocol.
Detection of viral release
DNA was extracted from culture supernatant using SMI-TEST EX-R&D (Medical & Biological Laboratories Co., Ltd) according to the manufacturer's protocol. All extracted DNA was dissolved in nuclease-free water and quantified by RT-PCR using HBc and HBs primer sets, respectively.
Immunofluorescence microscopy and fluorescence imaging
HBV-infected hepatocytes were fixed with 4% paraformaldehyde (PFA) for 15 min at 4°C and then washed three times with PBS. Cells were permeabilized with 0.05% Triton X-100 in PBS for 10 min at room temperature, blocked with 5 mg ml −1 BSA in PBST (0.04% Tween 20 in PBS) for 30 min and incubated with the targeting primary antibody diluted in blocking buffer at 4°C overnight. Following this, cells were incubated with secondary antibodies at room temperature for 1 h, then nuclei were stained with 4.6-dimaidino-2-phenylinodole (DAPI) and observed using a confocal laser microscope, TCS-SP (Leica).
Immunoblotting
Immunoblotting was performed as described previously (29) . Proteins were visualized by chemical luminescence using secondary antibodies conjugated with HRP. Antibodies used were: HBcAg (rabbit anti-HBcAg, Neomarkers, 1413R810A, Fremont, CA, USA), IPS-1 (rabbit anti-MAVS, Abcam ab25084), STING (rabbit, hMITA275-92, Immuno-Biological Laboratories Co, Ltd, Japan), NTCP (rabbit anti-SLC10A1, Atlas Antibody, HPA042727, Sweden), and β-actin (Sigma, Cat. No. A8481).
Flow cytometry analysis
Cells were detached from the culture dish by trypsin and fixed with 1% PFA for 15 min at room temperature, then washed with PBS three times. Cells were permeabilized with 0.05% Triton X-100 in PBS for 10 min at room temperature, blocked with 10% donkey serum in PBS for 30 min and incubated with the targeting primary antibody overnight at 4°C. Cells were washed with FACS buffer [HBSS(+), 0.02% BSA and 0.05%NaN 3 ] and then incubated with Alexa 647-conjugated IgG secondary antibody in FACS buffer at room temperature for 1 h. Cells were washed and then subjected to analysis by flow cytometry.
Microplate immunostaining for HBc
Cells were seeded in 96-well plates and then fixed with 4% PFA for 15 min at room temperature. Cells were then washed with PBS three times, permeabilized with 0.05% Triton X-100 in PBS for 10 min at room temperature, blocked with 10% donkey serum in PBS for 30 min and incubated with the targeting primary antibody diluted in blocking buffer at 4°C overnight. Cells were washed with TBST and then incubated with HRPconjugated IgG secondary antibody at room temperature for 1 h. After carefully washing with TBST, a TMB mixture (ELISA POD Substrate TMB Kit) was added to the plate to visualize the signal. After termination of the reaction by adding acid buffer, signals were quantified by photometer at an absorbance of 450 nm.
Southern blot
The HBV DNA probe was synthesized using a Random Primer DNA Labeling Kit (Takara). All extracted DNA samples underwent southern blotting analysis as previously described (30) . Steps were carried out in accordance with the manufacturer's protocol. Signals were visualized and analyzed using the FUJIFILM BAS-5000 image scanner.
CsCl gradient fractionation
CsCl density gradients (15 ml) ranging from 5 to 40% (w/w) in TNE (10 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 mM EDTA) were prepared using The Gradient Station (Biocomp). Concentrated culture medium (500 µl) from Hep38.7-Tet and i7 cells were carefully loaded onto the top of the gradient and centrifuged for 16 h at 28 000 rpm in a P28S2 swing rotor (HITACHI) at 15°C. Twenty-four fractions were collected using The Gradient Station and AC-5700P Micro Collector (ATTO), and HBs antigen and HBV DNA levels in each fraction were analyzed by ELISA and quantitative PCR, respectively. Fractions positive for HBs and HBV DNA were dialyzed by the Oscillatory Microdialysis System (Bio-Tech) and subjected to electron microscopy.
Ultrathin-section immuno-electron microscopy
Cells were fixed with 4% PFA and 2% glutaraldehyde overnight at 4°C (31) . Then, cells were incubated with 0.5% osmium tetroxide in 0.1 M phosphate buffer for 40 min at room temperature. After dehydration with ethanol, cells were embedded in epoxy resin (Luveak; Nacalai Tesque, Japan). Once the resin was polymerized, the cells were cut into ultrathin sections on an ultramicrotome, EM UC7 (Leica). Sections of the sample (50-nm thick) were etched on nickel grids with saturated sodium periodate solution (32), washed with PBS and treated with the blocking solution. The grids were then incubated with an anti-HBc mouse mAb. After being washed with PBS, they were incubated with a goat anti-mouse immunoglobulin conjugated to 10-nm gold particles. The samples were washed, fixed with 1% glutaraldehyde (GLA) and stained with 2% uranyl acetate (UA) solution and Reynolds lead. The digital images were recorded with a transmission electron microscope (TEM) operated at 80 kV.
Negative-staining immuno-electron microscopy
Supernatants were adsorbed to Formvar-coated nickel grids and prefixed with 4% PFA phosphate buffer solution (WAKO). The grids were washed, treated with blocking solution (Blocking One; Nacalai Tesque) and then incubated with an anti-HBs rabbit antibody. After being washed with PBS, they were incubated with a goat anti-rabbit immunoglobulin conjugated to 10-nm gold particles (BBI Solutions). The samples were washed, fixed with 1% GLA and negatively stained with 2% UA solution. The images were recorded using an HT7700 TEM (Hitachi) operated at 80 kV.
Statistical analysis
All experimental values are presented as the mean ± SE for at least three independent recordings. Data were analyzed using Statistical Product and Service Solutions software.
Results
Cytoplasmic RNA sensing negatively regulates HBV expression in ES2 cells
ES2 cells have a chromosomally integrated 1.3-fold HBV DNA copy and constitutively produce HBV antigens and infectious HBV. We first knocked down key components of anti-viral innate immunity by siRNA. IPS-1 is a critical adaptor for RLR signaling and its deficiency abrogates RLR-mediated anti-viral signaling (33, 34) . STING is a critical molecule in the cytoplasmic DNA-sensing pathway (35) . siRNA targeted to IPS-1 and STING significantly attenuated respective protein expression (Fig. 1A) . Intracellular HBc was detectable in ES2 cells and its level was markedly enhanced by IPS-1 knockdown; however, knockdown of STING did not affect its expression. The 1.3-fold HBV DNA in ES2 cells has a single BclI site at the 5′ end, therefore its transcript corresponding pre-genomic RNA (pgRNA) has a single BclI sequence. During the HBV life cycle, pgRNA is first converted to single-stranded DNA (ssDNA) by reverse transcription, and this ssDNA is processed to form a relaxed circular DNA (rcDNA), which is then converted to covalently closed circular DNA (cccDNA, encompassing 1-fold genome). Therefore, pgRNA transcribed from cccDNA has 2 BclI sequences (26) . Generation of cccDNA in ES2 cells has been demonstrated by digestion of HBV cDNA with BclI and SspI, where 132 and 200 bp fragments indicate that the cDNA is derived from cccDNA (26, 36) (Fig. 1B) . ES2 cells treated with control siRNA exhibited an RT-PCR product of 935 bp; however, its intensity was low. ES2 cells with a knockdown of IPS-1 expression showed a dramatic increase in the 935 bp band, as well as bands at 132 and 200 bp, indicating that depletion of IPS-1 markedly enhanced HBV transcription derived both from the chromosomal 1.3-fold HBV and cccDNA. STING knockdown singly or in combination with IPS-1 knockdown did not enhance HBV transcription. We examined intracellular mRNA levels for HBc and HBs by RT-PCR (Fig. 1C) , as well as The culture supernatants of cells in (C) were collected and subjected to DNA extraction by smi-TEST. The DNA was quantified by qPCR using specific primer sets for HBc and HBs, respectively. The relative DNA levels are indicated by considering the level of expression in control siRNAtransfected cells to be 1. *P < 0.05, **P < 0.01.
HBV DNA release into the culture supernatant (Fig. 1D) . The findings confirmed that IPS-1 negatively regulates HBV gene expression and release of HBV DNA into culture supernatant.
Generation of HepG2 cells stably expressing human NTCP and shRNA for IPS-1
To facilitate HBV infection in cell culture, we generated HepG2 cells stably expressing human NTCP, which functions as an entry receptor for HBV (12) , as a fusion with GFP. One of the clones, termed NtG20, showed high expression of hNTCPtGFP ( Fig. 2A) , as well as high susceptibility to HBV replication (Supplementary Figure S1, Figure S1 , available at International Immunology Online). One of the clones, termed NtG20.i7, exhibited diminished IPS-1 expression (Fig. 2B) as well as the highest HBV replication (Supplementary Figure S1 , available at International Immunology Online), and was, therefore, further used for this study. Microscopy of these cells confirmed that hNTCP-tGFP was primarily detectable on the plasma membranes of NtG20 and NtG20.i7 ( Fig. 2A and C) .
HBV infection in HepG2 and its derivative cell lines
To examine HBV infection and replication in HepG2-derived cell lines, we used Hep38.7-Tof cell culture supernatant as an HBV inoculum (Fig. 3A , hereafter named as HBV tof ), since it contained a higher amount of HBV DNA compared to that of ES2 cells or sera of human liver chimeric mice (data not shown). The cells were exposed to HBV at 1000 GEq/cell and cultivated thereafter as described in Fig. 3(B) . At 21 days after infection, cells were fixed to stain for HBc and analyzed by flow cytometry (Fig. 3C ). Hep38.7-Tof cells expressing HBV showed high expression of HBc. Fluorescence profiles of HepG2 cells, with or without HBV, were identical, indicating that the parental cells are hardly infected by HBV. HBV tof -infected NtG20 cells exhibited a slight increase in HBc expression, with NtG20.i7 showing higher HBc expression. Intracellular HBc was quantified to illustrate the amount of HBc-positive cells in infected cells (Fig. 3C, right panel) . We also examined HBV infectivity to PXB cells, which are fresh human hepatocytes isolated from a humanized liver in mice, and are used for HBV infection in vitro (37) . PXB cells supported HBV replication when exposed to sera from HBV-infected chimeric mice bearing human livers (HBV sera ) (Fig. 3E) . NtG20.i7 and PXB cells were exposed to HBV tof at 1000 GEq/cell and cultivated, as described in Fig. 3(D) . RT-PCR analysis revealed comparable viral replication between NtG20.i7 and PXB cells (Fig. 3E) . Viral translation was evaluated by detection of HBc 21 days post-infection (Fig. 3F) . NtG20.i7 cells exhibited comparable viral infectivity and expression compared to PXB cells.
NtG20.i7 cells allowed long-term maintenance of HBV replication
Although NtG20.i7 cells exhibited susceptibility to HBV, their efficiency was just above the detection level after 21 days. Therefore, we investigated longer cultivation after exposure to HBV at 1000 GEq/cell. NtG20.i7 cells were infected for up to 35 days without cell passage, as described in Fig. 4(A) . HBc protein expression was determined by immunoblotting ( Fig. 4B ) and was clearly detectable at 21 dpi, and continued to increase up to 35 dpi. Cellular mRNA levels for HBc, HBs and NTCP, and HBV DNA levels in culture supernatant, were elevated at 14-35 dpi (Fig. 4C and D) . These results indicated that the induction of viral replication was time-dependent. Finally, flow cytometry analysis indicated that HBc expression was significantly increased from 14 to 21 dpi and continued to increase up to 35 dpi (Fig. 4E) . Taken together, these findings showed that NtG20.i7 cell culture was able to maintain long-term persistent infection.
NtG20.i7 cells allowed de novo replication of HBV in longterm cell culture
The above findings indicated that NtG20.i7 cells were infected with HBV and maintained its replication for 35 days. The observed long-term maintenance of HBV expression may be due to two mechanisms: (i) stable propagation of initially infected cells and (ii) de novo infection through newly produced HBV virion. To explore these possibilities, we used the LHBs peptide, myr-47WT, which interferes with entry of HBV to host cells (12, 13, 38, 39) . NtG20.i7 cells were infected, as described in Fig. 5(A) , at 1000 GEq/cell, and treated with myr-47WT or a mutant myr-47N9K, which lacks inhibitory activity. For comparison, cells were also treated with Lamivudine (3TC), a reverse transcriptase inhibitor (6) . Culture supernatants were examined by HBs ELISA (Fig. 5B) , and cells were examined by microplate immunostaining assay for HBc (Fig. 5C, Methods section) . The results showed that expression of HBs and HBc was blocked by the myr-47WT peptide, but not by the mutant, suggesting de novo infection by newly produced HBV. To address the effect of these treatments on HBV-infected NtG20.i7 cells, we performed FACS analysis to examine HBc expression level (Supplementary Figure S4A , available at International Immunology Online). 3TC and Myr-47WT treated cells showed reduction in HBc expression compared to control. HBV DNA expression level was also quantified and similar tendency to HBc expression level was observed (Supplementary Figure S4B , available at International Immunology Online). Therefore, HBV expression was 3TC sensitive, suggesting that a canonical HBV life cycle occurs in these cells. To further address the release of infectious HBV, we examined the culture supernatant for HBV infectivity. Culture supernatant of HBV tof -infected NtG20.i7 cells was prepared at 21 dpi, concentrated (indicated as HBV inf ) and exposed to naive NtG20. i7 cells, as described in Fig. 5(D) . The infected cells were analyzed for HBc by immunoblotting (Fig. 5E) , and cellular RNA for HBc, HBs and NTCP were quantified by RT-PCR (Fig. 5F-H) . The results showed that HBV-infected NtG20.i7 cells produce infectious HBV, which is capable of causing re-infection in naive NtG20.i7 cells. On the basis of the results of viral detection in re-infection, we speculated the existence of cccDNA in primary infected cells for completing its viral life cycle.
Detection of cccDNA and virion-like structure in HBVinfected NtG20.i7 cells
According to the above findings, we speculate that NtG20. i7 cells support the full HBV replication cycle. Since cccDNA is a key template molecule for HBV transcription and replication, we attempted to detect it (30). Fig. 6(A) illustrates that NtG20.i7 cells infected with HBV for 35 days contained two viral DNA species, at positions 3.2 and 2.1 kb. These bands were examined by T5 exonuclease digestion (Supplementary Figure S2 , available at International Immunology Online) and were identified as rcDNA and cccDNA, respectively.
When we cultured HBV-infected NtG20.i7 cells for 28 days, we discovered that a high proportion of cells were positive for HBc (Fig. 6B) : the average ratio is 52.8 ± 6.4% and for Hep38.7-Tof cells is 88.3 ± 3.2%, by analyzing HBc staining cells/DAPI staining cells. This prompted us to observe viral particles in the infected NtG20.i7 cells by immuno-electron microscopy (immuno-EM). First, we performed ultrathin-section immuno-EM with HBc antibody staining (Fig. 6C) . Virionlike structures were found in the periphery of cells with HBc staining in the center. Because of antibody reactivity, we suspect that the inner core may correspond to the HBc, which is surrounded by a membrane-like structure 42 nm in diameter, corresponding to the reported infectious HBV particle. In addition, the whole structure is surrounded by membrane structures of around 100 nm in diameter. Similar structures were detected in Hep38.7-Tof cells, suggesting that this is relevant to HBV. We reasoned that the infectious HBV (42 nm in diameter) bud enters into the endoplasmic reticulum (ER) lumen and is transported to the cell periphery, and thus is surrounded by the ER and plasma membranes (illustrated in Fig. 6C) .
Furthermore, culture supernatant of NtG20.i7 cells infected with HBV tof for 21 days was examined by negative-staining immuno-EM using HBs antibody (Fig. 6D) . We observed a structure with anti-HBs reactivity of 42 nm in diameter. This is likely a mature infectious HBV Dane particle. In addition, similar structures were observed in the culture supernatant of Hep38.7-Tof cells. We also observed HBs-containing sub-viral particles in culture supernatant by negative-staining immuno-EM (Supplementary Figure S3 , available at International Immunology Online). Taken together, the findings of these experiments indicate that these viral structures are relevant to HBV replication.
Discussion
Innate immunity is the first line of defense against pathogen invasion. Nucleic acid sensing of viruses with different adaptors is indispensable for the initiation of antiviral responses. In this study, we explored relevant sensing adaptors for HBV infection and investigated the interplay of nascent innate immunity and NTCP expression during HBV infection. As a result, we identified IPS-1 as a critical innate adaptor against HBV and found that its depletion enhances viral activity.
Several reasons why HBV does not efficiently replicate in cell culture have been recently revealed. Unlike liver tissue, hepatic cell lines lack necessary factor(s) and express restriction factor(s), responsible for limiting HBV replication. NTCP, a critical factor for HBV entry, is hardly expressed in cell lines such as HepG2, over-expression of which could confer HBV susceptibility (NtG20, Fig. 3C ). However, HBV replication is much less efficient compared to primary human hepatocytes (data not shown), suggesting additional suppressive mechanisms. While we found that knockdown of IPS-1, a critical adaptor for RLR signaling, resulted in enhanced HBV replication in ES2 cells (Fig. 1) , it was reported that a cytoplasmic viral RNA sensor, RLR, is an additional restriction factor (23-25, 40, 41) . On the basis of these findings, we generated stable IPS-1 knockdown cells by using NtG20 as parental cells to examine RLR involvement in the HBV infection system. Six knockdown clones generated were investigated for IPS-1 expression and for HBV susceptibility (Supplementary Figure S1 , available at International Immunology Online). IPS-1 expression levels were negatively correlated with HBV replication among all clones, except clone 8, which showed substantial IPS-1 knockdown, but HBV replication was comparable to parental NtG20 cells, suggesting additional restriction factor(s). The NtG20.i7 clone exhibited both the lowest IPS-1 expression and the highest propagation of HBV; therefore, we used this clone for further analyses. Of note, in a widely used cell line HepG2-NTCP-C4 (C4) which is reported to be susceptible to HBV infection (27) , we also performed IPS-1 knockdown and observed higher infectivity than control (data not shown). Thus, enhancement of HBV infectivity is not restricted to our cell line. Considering NTCP expression with green fluorescence, NtG20.i7 might be a good tool to understand the interplay between HBV entry and NTCP. NtG20.i7 cells were stably maintained in culture and supported persistent HBV infection for as long as 35 days. Notably, NtG20.i7 cells exhibited comparable, or a little higher, HBV replication as PXB cells (Fig. 3E and  F) . While primary hepatocytes have limited cell division and detached from the culture dish at 35 days, NtG20.i7 cells supported HBV replication for as long as 35 days (Fig. 4) . Therefore, with improved culture conditions, NtG20.i7 has the potential to support HBV replication for >35 days. HBV gene expression (Fig. 4E) showed that HBV gene products in infected cells accumulated gradually >35 days. Although a high proportion of cells were infected at 35 days, cells did not show an obvious cytopathic effect. These features are consistent with HBV persistency in vivo.
Our results indicated that this long-term infection is mediated by de novo infection through the HBV virion (Fig. 5) . Consistent with this notion, culture supernatant of HBV-infected NtG20.i7 cells contained HBV infectivity, as well as virion and sub-viral particles observed by electron microscopy ( Fig. 6D; Supplementary Figure S3 , available at International Immunology Online). Moreover, ultrasectioning of HBV-infected NtG20.i7 cells revealed that enveloped HBV particles are surrounded by a multiple membrane structure located on the cell surface. These structures are similar to virus particle-containing vesicles observed in duck HBV-infected cells (42) . We speculate that these structures correspond to enveloped HBV budded into the ER lumen and transported to the cell periphery. However, it is not clear how these HBV virions surrounded by multiple membranes are released into the culture medium. The HBV/NtG20.i7 system will be useful for elucidation of this question.
In summary, we report the establishment of a HepG2-derived clone, NtG20.i7. NtG20i7 cells supported HBV replication with comparable efficiency as primary human hepatocytes. Because of its immortal nature, NtG20.i7 can support HBV replication for as long as 35 days, during which viral expression gradually continued to increase. Furthermore, HBV-infected NtG20.i7 cells produced infectious HBV in the culture supernatant. This unique cell culture system is useful for studying molecular mechanisms of HBV replication through combination with gene over-expression, knockdown and knockout techniques. Practically, this system is useful for large-scale anti-viral drug screening in vitro, as well as generation of tissue culture-adapted HBV clones, which will further improve HBV replication in vitro.
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